Sparkling Sciences Achieves U.S. INCI Certifications
TOMO YUME Group announced that its subsidiary, Sparkling Sciences, has achieved a remarkable milestone by obtaining dual certifications from the U.S. International Nomenclature Cosmetic Ingredient (INCI) system. This accomplishment reinforces the company’s expertise in exosome research and integrates a solid regulatory foundation for its expansion into the global markets for high-performance scalp, hair, and skincare.
Details of the Certifications
The certification validates two proprietary ingredients developed through Sparkling Sciences' pioneering biotechnology, highlighting their commitment to quality and innovation:
Human Hair Follicle Dermal Papilla Cell Exosomes (INCI ID: 40983)
This innovative ingredient is intended for advanced scalp care and hair root enhancement. The application of these exosomes demonstrates the company’s commitment to formulating superior products for the hair care beauty industry.
Organic Rice Bran-Derived Vesicles (INCI ID: 40956)
This versatile botanical ingredient is recognized for its ability to enhance skin texture, moisturize effectively, and add volume to hair. Sparkling Sciences has already integrated this ingredient into various commercial formulations, showcasing its market readiness.
Quotes from Leadership
Dr. Fang-Chen Kao, CEO of Sparkling Sciences, commented on this achievement: "The acquisition of U.S. INCI certification signifies a pivotal moment in our research and development journey, marking international recognition of our precise technical capabilities. Our Dermal Papilla Cell Exosomes exemplify our strength in delivering next-generation scalp solutions. With our motto 'From Science to Beauty and Health,' we are swiftly broadening applications across human and animal healthcare sectors."
Expansion in Production Capabilities
To meet the rising global demand for its products, Sparkling Sciences is setting up a cutting-edge R&D and manufacturing facility. This state-of-the-art site is projected to be operational in 2026 and will launch with Good Tissue Practice (GTP) validation, ensuring traceability and safety in the production process. The facility will also implement Good Manufacturing Practice (GMP) protocols in phases, significantly increasing production capacity for high-purity exosome ingredients. This expansion positions TOMO YUME Group to take a leading role in the global biotech beauty market.
About Sparkling Sciences
Company Name: Sparkling Sciences
Headquarters: Taipei & Taichung, Taiwan
CEO: Dr. Fang-Chen Kao
Business Scope: Research, development, and manufacturing of exosome ingredients; planning and sales of skincare and healthcare products
Affiliated Companies: TOMO YUME Group; ArcBio Co., Ltd. (Tokyo)
Media Contact
Media Contact: Johnson Chen
+886939631095
Frequently Asked Questions
What are the recent achievements of Sparkling Sciences?
Sparkling Sciences recently obtained dual U.S. INCI certifications for two innovative ingredients, solidifying its growth in global skincare and haircare markets.
What are Human Hair Follicle Dermal Papilla Cell Exosomes?
This is a cutting-edge ingredient aimed at enhancing scalp health and supporting hair root conditioning in cosmetic products.
What benefits do Organic Rice Bran-Derived Vesicles provide?
These vesicles improve hydration, skin texture, and overall hair volume. They are already featured in several commercial skincare formulations.
How is Sparkling Sciences preparing for future growth?
The company is constructing a new R&D and manufacturing facility, expected to start operating in 2026, which will increase its production capacity significantly.
Who leads Sparkling Sciences?
The company is led by Dr. Fang-Chen Kao, who emphasizes the synergy of science and beauty in their products.